- Home
- BLTE vs RPD Comparison
BLTE vs RPD Comparison
Compare BLTE & RPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLTE
- RPD
- Stock Information
- Founded
- BLTE 2018
- RPD 2000
- Country
- BLTE United States
- RPD United States
- Employees
- BLTE N/A
- RPD N/A
- Industry
- BLTE Biotechnology: Pharmaceutical Preparations
- RPD Computer Software: Prepackaged Software
- Sector
- BLTE Health Care
- RPD Technology
- Exchange
- BLTE Nasdaq
- RPD Nasdaq
- Market Cap
- BLTE 2.1B
- RPD 2.4B
- IPO Year
- BLTE 2022
- RPD 2015
- Fundamental
- Price
- BLTE $58.91
- RPD $39.29
- Analyst Decision
- BLTE Strong Buy
- RPD Buy
- Analyst Count
- BLTE 4
- RPD 18
- Target Price
- BLTE $96.33
- RPD $44.76
- AVG Volume (30 Days)
- BLTE 46.8K
- RPD 585.9K
- Earning Date
- BLTE 03-10-2025
- RPD 02-12-2025
- Dividend Yield
- BLTE N/A
- RPD N/A
- EPS Growth
- BLTE N/A
- RPD N/A
- EPS
- BLTE N/A
- RPD 0.66
- Revenue
- BLTE N/A
- RPD $833,014,000.00
- Revenue This Year
- BLTE N/A
- RPD $9.10
- Revenue Next Year
- BLTE N/A
- RPD $5.35
- P/E Ratio
- BLTE N/A
- RPD $59.80
- Revenue Growth
- BLTE N/A
- RPD 10.05
- 52 Week Low
- BLTE $31.01
- RPD $32.95
- 52 Week High
- BLTE $86.53
- RPD $61.88
- Technical
- Relative Strength Index (RSI)
- BLTE 46.75
- RPD 45.96
- Support Level
- BLTE $52.03
- RPD $38.67
- Resistance Level
- BLTE $61.66
- RPD $40.42
- Average True Range (ATR)
- BLTE 3.51
- RPD 1.12
- MACD
- BLTE 0.25
- RPD 0.03
- Stochastic Oscillator
- BLTE 42.55
- RPD 45.14
About BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
About RPD Rapid7 Inc.
Founded in 2000, Rapid7 is a cybersecurity company that began providing vulnerability management solutions. It has, however, expanded its portfolio to provide extended detection and response; security information and event management; cloud security, threat intelligence, and application security; and security orchestration, automation, and response. The Boston-based company went public in 2015.